Nocion Therapeutics
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
2
Funding Rounds
$54.0m
Money raised
Overview
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** Be** | - | - | - |
| Cl****** J. Wo*** | - | - | - |
| Br*** Le** | - | - | - |
Funding series
Funding Series Analysis
The company Nocion Therapeutics has raised a total of $27m in funding over 2 rounds.
Key Insights:
- Nocion Therapeutics Series A round, April 2019: $27m
- Nocion Therapeutics funding round, April 2019: $27m
Nocion Therapeutics Series A round, April 2019
$27m
Nocion Therapeutics funding round, April 2019
$27m
Industries
Nocion Therapeutics is active in the following industries: